跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 216 条关于
“ornithine decarboxylase”
全部
216
临床试验
90
药物
32
机构
0
资讯
94
去年
Eflornithine Combo Fails to Meet Primary Endpoint in Phase III Brain Cancer Trial
去年
Eflornithine and Lomustine Combination Shows Survival Benefit in Recurrent Astrocytoma
10个月前
Orbus Therapeutics Reports Positive Phase 3 STELLAR Trial Results for Eflornithine in Recurrent IDH-Mutant Astrocytoma
5个月前
Penn State Launches Phase II Trial of DFMO for Pediatric Bone Cancers Following FDA Approval in Neuroblastoma
去年
Eflornithine (Iwilfin) Approved for High-Risk Neuroblastoma to Reduce Relapse Risk
去年
Australia Approves IFINWIL (Eflornithine) for High-Risk Neuroblastoma Treatment
4个月前
Repurposed Sleeping Sickness Drug Shows Promise for Ultra-Rare Bachmann-Bupp Syndrome
去年
Yaqrit Advances L-ornithine Phenylacetate to Phase 3 for Acute Hepatic Encephalopathy Treatment
去年
FDA Approves First Gene Therapy for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
去年
FDA Approves PTC Therapeutics' Kebillidi, First Gene Therapy for AADC Deficiency
第 1 页,共 10 页
上一页
下一页